Literature DB >> 2841535

Decreased plasma levels of cyclic GMP in patients with chest pain and angiographically normal coronary arteries.

J Ahlner1, R G Andersson, K L Axelsson, B Bergdahl, U Dahlström, E Swahn.   

Abstract

Plasma levels of cyclic nucleotides were determined by radioimmunoassay in patients with (1) angina-like chest pain and normal coronary arteries (suspected spasm angina), (2) exercise-induced angina, and (3) heart diseases other than angina pectoris, as well as in (4) normal subjects. The concentration of cyclic GMP in plasma was significantly lower (by at least three-fold) in patients with suspected spasm angina, as compared with the other groups. No statistically significant difference in the plasma levels of cAMP was observed between the different patient groups. The low cGMP levels in plasma from patients with angina-like chest pain and normal coronary arteries might be an indication of a defect in the vasculature, making it more sensitive to contractile stimuli.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841535     DOI: 10.1007/BF01876171

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  24 in total

Review 1.  Coronary-artery spasm.

Authors:  L D Hillis; E Braunwald
Journal:  N Engl J Med       Date:  1978-09-28       Impact factor: 91.245

2.  Is variant angina the coronary manifestation of a generalized vasospastic disorder?

Authors:  D Miller; D D Waters; W Warnica; J Szlachcic; J Kreeft; P Théroux
Journal:  N Engl J Med       Date:  1981-03-26       Impact factor: 91.245

Review 3.  The role of endothelium in the responses of vascular smooth muscle to drugs.

Authors:  R F Furchgott
Journal:  Annu Rev Pharmacol Toxicol       Date:  1984       Impact factor: 13.820

4.  Effect of 8-bromo-cyclic guanosine monophosphate (cGMP) on coronary artery constriction in isolated rabbit hearts.

Authors:  R J Bing; M Saeed
Journal:  J Am Coll Cardiol       Date:  1986-08       Impact factor: 24.094

5.  Altered adrenergic activity in coronary arterial spasm: insight into mechanism based on study of coronary hemodynamics and the electrocardiogram.

Authors:  D R Ricci; A E Orlick; P R Cipriano; D F Guthaner; D C Harrison
Journal:  Am J Cardiol       Date:  1979-06       Impact factor: 2.778

6.  Correlation between vascular smooth muscle relaxation and increase in cyclic GMP induced by some organic nitro esters.

Authors:  K L Axelsson; R G Andersson; J E Wikberg
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1981-10

7.  Increased plasma cyclic nucleotide concentrations in congestive heart failure.

Authors:  K Ogawa; H Shiozu; K Mizuno; M Ban; T Ito; T Satake
Journal:  Br Heart J       Date:  1984-11

8.  Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man.

Authors:  A E Broadus; N I Kaminsky; J G Hardman; E W Sutherland; G W Liddle
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

9.  Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin.

Authors:  C A Gruetter; D Y Gruetter; J E Lyon; P J Kadowitz; L J Ignarro
Journal:  J Pharmacol Exp Ther       Date:  1981-10       Impact factor: 4.030

10.  Effects of atrial natriuretic factor, sodium nitroprusside, and acetylcholine on cyclic GMP levels and relaxation in rat aorta.

Authors:  R M Rapoport; S A Waldman; K Schwartz; R J Winquist; F Murad
Journal:  Eur J Pharmacol       Date:  1985-09-24       Impact factor: 4.432

View more
  1 in total

1.  Alterations in circulating cyclic guanosine monophosphate (c-GMP) during short and long ischemia in preconditioning.

Authors:  E K Iliodromitis; C C Papadopoulos; M Markianos; I A Paraskevaidis; Z S Kyriakides; D T Kremastinos
Journal:  Basic Res Cardiol       Date:  1996 May-Jun       Impact factor: 17.165

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.